U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07207564) titled 'Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk' on Sept. 26.
Brief Summary: The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Study Start Date: Aug. 28
Study Type: OBSERVATIONAL
Condition:
Breast Carcinoma
Intervention:
OTHER: Non-Interventional Study
Non-interventional study
Recruitment Status: RECRUITING
Sponsor: Mayo Clinic
Published by HT Digital Content Services with permission from Health Daily Digest....